WESTPORT, CT (Reuters Health) - Epidemiological evidence suggests that the HIV-1 epidemic in homosexuals and intravenous drug users in Western countries originated from different sources.
Dr. Carla Kuiken from Los Alamos National Laboratory in Los Alamos, New Mexico, and colleagues analyzed the relationship of various HIV-1 variants within subtype B (the most prevalent subtype in Western countries) in homosexuals and intravenous drug users in Sweden, Norway and Holland in an effort to understand how the epidemic might have spread.
In both Sweden and Norway, the two risk groups carried distinct HIV-1 variants, the authors report in the November issue of the American Journal of Epidemiology. Moreover, the mutations shared by Swedish and Dutch drug users were common, whereas those unique to each country were relatively rare.
Similarly, the sequences from Norwegian and Dutch homosexuals seemed to be indistinguishable, the researchers note.
"Differences between homosexual and intravenous drug user virus populations appear to be ubiquitous in Northern Europe," the authors conclude. "Based on the available data, the most plausible scenario seems to be that the subtype B virus was carried out of Africa and introduced into the Western homosexual community by one person."
The researchers postulate that the virus then spread to other risk groups in the U.S., where the virus evolved independently, remaining relatively homogeneous within the separate risk groups.
"Sequencing of more virus variants from a large number of U.S. intravenous drug users from different geographic locations would seem to be the best way to determine the plausibility of this scenario," they assert.
Weekly Rounds: Four Years of COVID-19, AORN 2024 Conference Coverage, and More
March 18th 2024Here are 5 highlights from Infection Control Today®'s (ICT®’s) wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders to the news that infection preventionists and other health care professionals can use on their jobs.
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
Could Empathy Help Overcome Vaccine Hesitancy?
March 14th 2024Research findings reveal that correcting misinformation about vaccination can remarkably transform individuals' attitudes toward it. This highlights the crucial role of accurate information in making informed decisions about vaccination.
Empowering Safety: A Massachusetts General Hospital Team Is Pushing for Smoke-Free ORs
March 13th 2024At the AORN’s International Surgical Conference & Expo 2024, a team from Massachusetts General Hospital (MGH) showcased their transformative project, "Becoming Smoke-Free in the OR." This initiative underscored the critical need for smoke evacuation in surgical settings.
Hand Hygiene Practices in the Operating Room: A Collaborative Endeavor
March 13th 2024As explained on a poster at AORN 2024, perioperative nurses and infection preventionists unite in a proactive campaign to elevate hand hygiene within the operating room, resulting in improved adherence, decreased infections, and fortified patient outcomes.